Researchers have found that persistent fatigue in breast cancer survivors may be caused by disruption in the autonomic system, and could make some patients…
Breast cancer strikes 1 in 8 American women. This article discusses recent diagnostic and treatment advances (including some you may not know about) that…
A study presented at the American Society of Clinical Oncology June meeting found that removing additional axillary lymph nodes to look for breast cancer…
The U.S. Food and Drug Administration has approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer…
Johnson & Johnson’s Campaign for Nursing’s Future In 2002, Johnson & Johnson launched the Campaign for Nursing’s Future to enhance the image of nursing,…
The U.S. Food and Drug Administration has approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced…